semaglutide franklin Novo Nordisk Launches National “My Ozempic® Era” Campaign Celebrating Stories of Inspirational Ozempic® Patients GLP-1 Weight Loss Medication in

Efficacy and Safety of Flibanserin in Postmenopausal Women with Hypoactive Sexual Desire Disorder Results of the SNOWDROP Trial

Systemic autoimmune diseases triggered after tattooing: cases of sarcoidosis, lupus-like reactions, myositis, and other systemic inflammatory disorders have been reported after tattooing

A patient with high GLP1R expression may experience robust appetite suppression at standard doses, while another with lower expression might require dose escalation or alternative compounds

Further information regarding the webcast, including the web address for the webcast, will be made available no later than two (2) business days before the meeting in the Event Materials section of this web page